Hu et al. demonstrated that miR-339 is up-regulated in stem cell leukemia/lymphoma syndrome and promotes the development of stem cell leukemia/lymphoma syndrome via suppressing BCL211 and BAX expression (19). The gene discussed is BAX; the disease is acute leukemia.